Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 6 days ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Pfizer lifts profit view on cost cuts, higher COVID vaccine demand
Reuters· 1 hour ago, opens new tab lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid demand
Reuters via Yahoo Finance· 2 hours agoPfizer lifted its annual profit forecast on Wednesday, and reported first-quarter results that...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks· 1 day agoBioNTech’s top line currently comprises sales of its mRNA-based COVID-19 vaccine, Comirnaty, developed ...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 6 days agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer-...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 6 days agoWhat's Going On With Pfizer Stock On Thursday?
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 6 days agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 7 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 5 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...